MEDBOT-B (02252) announces profit growth, with an expected mid-term net profit of approximately 28 to 40 million RMB, turning losses into profits year-on-year.

MEDBOT-B (02252) issued an announcement that the board of directors expects the company to change from a net loss to a net profit in the six months ending on June 30, 2026, with an expected net profit of approximately RMB 28 million to RMB 40 million. The company had a net loss of RMB 115 million in the six months ending on June 30, 2025. This marks the first time the company has achieved a profit in a half-year period. The company's turnaround from loss to profit during the reporting period can be attributed to the following reasons: First, a significant increase in revenue - during the reporting period, the group's revenue increased by about 200% to 230% year-on-year. Siasun Robot&Automation's TMIF surgery achieved strong growth in both domestic and overseas markets, with overseas market revenue increasing by over 450%. This growth is due to the strong technical competitiveness and clinical application performance of the products, as well as the effective synergy of MICROPORT's overseas sales channels and resources, resulting in improved market coverage depth and breadth. Second, a significant improvement in gross margin - during the reporting period, the company's overall gross margin increased by over 15 percentage points compared to the same period last year. This improvement is due to the dilution effect of fixed costs brought about by the expansion of production scale, as well as the continuous optimization of production processes leading to effective narrowing of direct labor costs. The phased implementation of cost reduction processes also helped to gradually lower material costs, and the continuous optimization of the product portfolio, especially the rapid growth of high-margin consumable income, also contributed to the steady increase in gross margin. Third, continuous optimization of expense control - during the reporting period, the company continued to achieve positive results in expense control and resource allocation, with operating expenses as a percentage of revenue significantly decreasing, further enhancing overall operational efficiency. In summary, the combined effect of revenue growth, gross margin improvement, and expense control optimization has laid a solid foundation for the company to achieve a profit for the first time in the reporting period.